+1 (202) 780-3397
Editorial - Journal of Clinical Pathology and Laboratory Medicine (2020) Volume 2, Issue 2
Market Analysis- Pathology
2nd World Congress on Pathology” will be held in October 28-29, 2020 at Zurich, Switzerland. Major attractions of this event would revolve around keynote presentations, oral presentations and poster presentations. This year we are focusing on the theme “Reconnoitre exceptional knowledge in Pathology and Related Research ". Pathology is the study of the causes and effects of disease or injury. The word pathology also refers to the study of disease in general, incorporating a wide range of bioscience research fields and medical practices.
Scope and Importance:
The Worldwide Market of pathology is anticipated to $437 million by 2018 with a CAGR of 11.8% from 2013 to 2018. As indicated, there are 24,785 pathologists working with patients in Australia and it has reached a revenue of 3 billion dollars with a compound annual growth rate of 1.6% between 2014 and 2019. The key factors influencing the evolution of this market include increasing prevalence of cancer, increasing adoption of digital pathology to enhance lab efficiency, increasing initiatives by governments & industry players, ease of consultation, and mounting bids of digital pathology in medical development and companion diagnostics. The worldwide market for anatomic pathology will possibly improve up at a consistent pace of 6.5% from 2017 to 2025, estimation of a report done by Transparency Market Research. At this pace, the market is anticipated from US$17,318.0 Mn in 2016 to US$30,314.5 Mn by the end of 2025. Pathology usage increases with an increase in the prevalence of diseases and with mounting diseased population. Pathology is used globally for applications influencing research by academic personalities, disease diagnosis in clinical and healthcare centers, and in the discovery of new drugs.
Disease Diagnosis which is recorded to be $11.9 billion in the year 2013 is about to reach $13.1 billion by 2019 with a developing CAGR of 1.6% between 2014 and 2019. Drug discovery is relied upon to reach $85.8 billion by 2022 from $54.7 billion by 2017 with a development in CAGR up to 9.4% from 2017 to 2022.
Global universities:
· Universite Paris Saclay
· PSL Research University Paris
· Universite Sorbonne Paris
· Universite de Lyon
· University of Aix-Marseille
· Languedoc-Roussillon Universites
· University of Strasbourg
TOP HOSPITALS:
· Assistance Publique Hôpitaux de Paris
· L’Institut Curie
· Centre Hospitalier Universitaire de Lyon hôpitaux de Lyon
· Hôpitaux de Rouen
· Centre Hospitalier Universitaire de Toulouse
· Centre Hospitalier Regional Universitaire de Lille
· Centre Hospitalier Universitaire Chu Chr de Montpellier
Author(s): Editor